Oncological Outcomes After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in the Treatment of Peritoneal Carcinomatosis.
Fatah TidadiniJulio AbbaJean-Louis QuesadaBertrand TrillingAline BonneAlison FooteJean-Luc FaucheronCatherine ArvieuxPublished in: Journal of gastrointestinal cancer (2022)
The OS was in line with the literature. PIPAC could delay oncological progression and improve survival. These encouraging results justify the ongoing and future evaluations of PIPAC by prospective randomized trials.